Publication date: Dec 30, 2024
Highly mutable pathogens generate viral diversity that impacts virulence, transmissibility, treatment, and thwarts acquired immunity. We previously described C19-SPAR-Seq, a high-throughput, next-generation sequencing platform to detect SARS-CoV-2 that we here deployed to systematically profile variant dynamics of SARS-CoV-2 for over 3 years in a large, North American urban environment (Toronto, Canada). Sequencing of the ACE2 receptor binding motif and polybasic furin cleavage site of the Spike gene in over 70,000 patients revealed that population sweeps of canonical variants of concern (VOCs) occurred in repeating wavelets. Furthermore, we found that VOC mutant derivatives and putative quasispecies that targeted functionally important residues and were found in future VOCs arose frequently, but were always extinguished. Systematic screening of functionally relevant domains in pathogens could thus provide a powerful tool for monitoring spread and mutational trajectories, particularly those with zoonotic potential.
Open Access PDF
Semantics
| Type | Source | Name |
|---|---|---|
| disease | IDO | virulence |
| disease | IDO | site |
| disease | MESH | Amelia |
| disease | MESH | viral infections |
| disease | MESH | COVID 19 pandemic |
| disease | IDO | process |
| drug | DRUGBANK | 7-Methyl-Gpppa |
| pathway | REACTOME | Reproduction |
| drug | DRUGBANK | Ranitidine |
| disease | MESH | viral load |
| drug | DRUGBANK | Amino acids |
| disease | IDO | assay |
| drug | DRUGBANK | Trestolone |
| disease | IDO | history |
| drug | DRUGBANK | Etoperidone |
| disease | MESH | point mutations |
| disease | IDO | quality |
| disease | IDO | production |
| disease | IDO | replication |
| drug | DRUGBANK | Ademetionine |
| disease | IDO | infectivity |
| drug | DRUGBANK | Succimer |
| drug | DRUGBANK | Gold |